{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:43:12Z","timestamp":1791333792890,"version":"4.3.1"},"reference-count":173,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R00 EY029373"],"award-info":[{"award-number":["R00 EY029373"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY035658"],"award-info":[{"award-number":["R01 EY035658"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25POST1372631\/2025-2026"],"award-info":[{"award-number":["25POST1372631\/2025-2026"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jpet.2025.103738","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:13:06Z","timestamp":1767082386000},"page":"103738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recent advances and future challenges in nanosystems for ocular drug delivery"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-9404","authenticated-orcid":false,"given":"Rami A.","family":"Shahror","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman Y.","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103738_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijbiomac.2018.01.120","article-title":"Biological macromolecules for ophthalmic drug delivery to treat ocular diseases","volume":"110","author":"Krishnaswami","year":"2018","journal-title":"Int J Biol Macromol"},{"issue":"29","key":"10.1016\/j.jpet.2025.103738_bib3","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200914119","article-title":"Cell atlas of the human ocular anterior segment: tissue-specific and shared cell types","volume":"119","author":"van Zyl","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.jpet.2025.103738_bib4","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1167\/iovs.19-28632","article-title":"The eye sees eye to eye with the immune system: the 2019 proctor lecture","volume":"60","author":"Niederkorn","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-024-03058-y","article-title":"Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions","volume":"21","author":"Shahror","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib6","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1167\/iovs.08-1755","article-title":"Role of NADPH oxidase in retinal vascular inflammation","volume":"49","author":"Al-Shabrawey","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jpet.2025.103738_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-neuro-071714-033835","article-title":"Neuronal and vascular interactions","volume":"38","author":"Andreone","year":"2015","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/febs.16330","article-title":"The blood-retina barrier in health and disease","volume":"290","author":"O\u2019Leary","year":"2023","journal-title":"FEBS J"},{"issue":"13","key":"10.1016\/j.jpet.2025.103738_bib9","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1167\/iovs.15-16936","article-title":"Modulating the transport characteristics of Bruch\u2019s membrane with steroidal glycosides and its relevance to age-related macular degeneration (AMD)","volume":"56","author":"Lee","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jpet.2025.103738_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","article-title":"The inner blood-retinal barrier: cellular basis and development","volume":"139","author":"D\u00edaz-Cor\u00e1nguez","year":"2017","journal-title":"Vision Res"},{"issue":"12","key":"10.1016\/j.jpet.2025.103738_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4155\/tde.14.75","article-title":"Advances in ophthalmic drug delivery","volume":"5","author":"Morrison","year":"2014","journal-title":"Ther Deliv"},{"key":"10.1016\/j.jpet.2025.103738_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","article-title":"Complexity of the tear film: importance in homeostasis and dysfunction during disease","volume":"117","author":"Dartt","year":"2013","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17434440.2018.1435271","article-title":"The tear turnover and tear clearance tests \u2013 a review","volume":"15","author":"Garaszczuk","year":"2018","journal-title":"Expert Rev Med Devices"},{"issue":"46","key":"10.1016\/j.jpet.2025.103738_bib14","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.drudis.2016.12.008","article-title":"In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond","volume":"22","author":"Destruel","year":"2017","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.14798","article-title":"Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival","volume":"1514","author":"Kuo","year":"2022","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.jpet.2025.103738_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/02713683.2012.700756","article-title":"Structural and functional alteration of corneal epithelial barrier under inflammatory conditions","volume":"37","author":"Contreras-Ruiz","year":"2012","journal-title":"Curr Eye Res"},{"issue":"13","key":"10.1016\/j.jpet.2025.103738_bib22","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.3390\/ijms25137098","article-title":"Nanostructure-mediated transport of therapeutics through epithelial barriers","volume":"25","author":"Hansen","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bpj.2015.10.002","article-title":"Diffusion regulation in the vitreous humor","volume":"109","author":"K\u00e4sdorf","year":"2015","journal-title":"Biophys J"},{"issue":"12","key":"10.1016\/j.jpet.2025.103738_bib24","doi-asserted-by":"crossref","first-page":"8626","DOI":"10.1167\/iovs.14-15225","article-title":"Quantitative imaging of enzymatic vitreolysis-induced fiber remodeling","volume":"55","author":"Filas","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jpet.2025.103738_bib25","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2217\/nnm.12.202","article-title":"Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy","volume":"8","author":"Martens","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.jpet.2025.103738_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2015.01.030","article-title":"Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy","volume":"202","author":"Martens","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.jpet.2025.103738_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jpet.2025.103738_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejpb.2019.04.006","article-title":"Ultrafast in situ forming poly(ethylene glycol)-poly(amido amine) hydrogels with tunable drug release properties via controllable degradation rates","volume":"139","author":"Buwalda","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib29","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.drudis.2019.05.031","article-title":"Recent advances in intraocular sustained-release drug delivery devices","volume":"24","author":"Cao","year":"2019","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/10717544.2022.2069301","article-title":"The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery","volume":"29","author":"Ranade","year":"2022","journal-title":"Drug Deliv"},{"issue":"9","key":"10.1016\/j.jpet.2025.103738_bib31","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10792-020-01391-8","article-title":"Sustained subconjunctival drug delivery systems: current trends and future perspectives","volume":"40","author":"Rafiei","year":"2020","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/bioengineering9010041","article-title":"Targeting ocular drug delivery: an examination of local anatomy and current approaches","volume":"9","author":"Dosmar","year":"2022","journal-title":"Bioengineering (Basel)"},{"issue":"5\u20136","key":"10.1016\/j.jpet.2025.103738_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jpet.2025.103738_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib36","article-title":"Peribulbar versus retrobulbar anaesthesia for cataract surgery","volume":"2015","author":"Alhassan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048188","article-title":"Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry","volume":"7","author":"Tyagi","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.jpet.2025.103738_bib38","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.3390\/jcm11164717","article-title":"Subretinal injection techniques for retinal disease: a review","volume":"11","author":"Irigoyen","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib39","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The Lancet Global Health Commission on Global Eye Health: vision beyond 2020","volume":"9","author":"Burton","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.18433\/J3DP43","article-title":"Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations","volume":"17","author":"Almeida","year":"2014","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.jpet.2025.103738_bib41","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ijbiomac.2018.05.113","article-title":"Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride","volume":"116","author":"Liu","year":"2018","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2011.11.022","article-title":"Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice","volume":"160","author":"Hagigit","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.jpet.2025.103738_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.08.048","article-title":"Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: formulation development, in-vitro and in-vivo studies","volume":"148","author":"Akhter","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.drudis.2016.10.015","article-title":"Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins","volume":"22","author":"Radhakrishnan","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jpet.2025.103738_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2017.01.016","article-title":"Ultrasound-enhanced penetration through sclera depends on frequency of sonication and size of macromolecules","volume":"100","author":"Chau","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/nnm-2016-0379","article-title":"Drug delivery to the eye: what benefits do nanocarriers offer?","volume":"12","author":"Joseph","year":"2017","journal-title":"Nanomedicine (Lond)"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1473","article-title":"Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases","volume":"10","author":"Bisht","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.jpet.2025.103738_bib48","author":"Turunen"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.jpet.2025.103738_bib50","article-title":"Intraocular injectable hydrogels for the delivery of cells and nanoparticles","volume":"32","author":"Ibeas Moreno","year":"2025","journal-title":"Mater Today Bio"},{"issue":"9","key":"10.1016\/j.jpet.2025.103738_bib51","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/02713683.2017.1302590","article-title":"In vivo efficacy of an injectable microsphere-hydrogel ocular drug delivery system","volume":"42","author":"Osswald","year":"2017","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/pharmaceutics13020176","article-title":"An injectable nano-enabled thermogel to attain controlled delivery of p11 peptide for the potential treatment of ocular angiogenic disorders of the posterior segment","volume":"13","author":"du Toit","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2025.103738_bib53","article-title":"A novel, liposome-loaded, injectable hydrogel for enhanced treatment of choroidal neovascularization by sub-tenon\u2019s injection","volume":"20","author":"Li","year":"2022","journal-title":"Mater Today Nano"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1548","article-title":"Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases","volume":"11","author":"Srinivasarao","year":"2019","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.jpet.2025.103738_bib55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res Lett"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102154","article-title":"Lipid-based eye drop formulations for the management of evaporative dry eyes","volume":"47","author":"Maulvi","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.jpet.2025.103738_bib59","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","article-title":"Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface","volume":"328","author":"Tavakoli","year":"2020","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.09.016","article-title":"Vesicular systems in ocular drug delivery: an overview","volume":"269","author":"Kaur","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jpet.2025.103738_bib61","article-title":"Tacrolimus loaded cationic liposomes for dry eye treatment","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib62","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jsps.2018.01.005","article-title":"Ocular administration of acetazolamide microsponges in situ gel formulations","volume":"26","author":"Obiedallah","year":"2018","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jpet.2025.103738_bib63","article-title":"Design and evaluation of mucoadhesive in situ liposomal gel for sustained ocular delivery of travoprost using two steps factorial design","volume":"61","author":"Shukr","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib64","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/gels8100635","article-title":"Novel metoprolol-loaded chitosan-coated deformable liposomes in thermosensitive in situ gels for the management of glaucoma: a repurposing approach","volume":"8","author":"Badran","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.jpet.2025.103738_bib65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jtos.2023.05.013","article-title":"New trends towards glaucoma treatment: topical osmoprotective microemulsions loaded with latanoprost","volume":"29","author":"L\u00f3pez-Cano","year":"2023","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib66","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1007\/s13346-024-01584-z","article-title":"Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents","volume":"14","author":"Brugnera","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.jpet.2025.103738_bib67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2018.12.015","article-title":"Gelatinized core liposomes: a new Trojan horse for the development of a novel timolol maleate glaucoma medication","volume":"556","author":"Hathout","year":"2019","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.jpet.2025.103738_bib68","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/pharmaceutics13122093","article-title":"Preparation of liposomal formulations for ocular delivery of thymoquinone: in vitro evaluation in HCEC-2 e HConEC cells","volume":"13","author":"Landucci","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2025.103738_bib69","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jconrel.2024.02.043","article-title":"Mucoadhesive liposomal delivery system synergizing anti-inflammation and anti-oxidation for enhanced treatment against dry eye disease","volume":"368","author":"Huang","year":"2024","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib70","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/pharmaceutics13101698","article-title":"Development of lactoferrin-loaded liposomes for the management of dry eye disease and ocular inflammation","volume":"13","author":"L\u00f3pez-Machado","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2025.103738_bib71","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.2147\/IJN.S301717","article-title":"Combination nanotherapeutics for dry eye disease treatment in a rabbit model","volume":"16","author":"Huang","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jpet.2025.103738_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118808","article-title":"Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis","volume":"572","author":"Roy","year":"2019","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib73","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/02713683.2020.1728777","article-title":"Anti-microbial effect and in vivo ocular delivery of ciprofloxacin-loaded liposome through rabbit\u2019s eye","volume":"45","author":"Feghhi","year":"2020","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/molecules27030733","article-title":"Enhancing ocular bioavailability of ciprofloxacin using colloidal lipid-based carrier for the management of post-surgical infection","volume":"27","author":"Al-Joufi","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib75","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/ab97a2","article-title":"The new ophthalmic formulation for infection control by combining collagen\/gelatin\/alginate biomaterial with liposomal chloramphenicol","volume":"6","author":"Chang","year":"2020","journal-title":"Biomed Phys Eng Express"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib76","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ab9510","article-title":"Liposomal dexamethasone-moxifloxacin nanoparticle combinations with collagen\/gelatin\/alginate hydrogel for corneal infection treatment and wound healing","volume":"15","author":"Chang","year":"2020","journal-title":"Biomed Mater"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib77","first-page":"205","article-title":"Ocular dorzolamide nanoliposomes for prolonged IOP reduction: in-vitroand in-vivo evaluation in rabbits","volume":"15","author":"Kouchak","year":"2016","journal-title":"Iran J Pharm Res"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib78","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3390\/pharmaceutics12050465","article-title":"Fabrication of Transgelosomes for enhancing the ocular delivery of acetazolamide: statistical optimization, in vitro characterization, and in vivo study","volume":"12","author":"Mazyed","year":"2020","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.jpet.2025.103738_bib79","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3390\/pharmaceutics13122010","article-title":"Synergistic effect of acetazolamide-(2-hydroxy)propyl \u03b2-cyclodextrin in timolol liposomes for decreasing and prolonging intraocular pressure levels","volume":"13","author":"Arroyo-Garc\u00eda","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib80","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12249-015-0382-1","article-title":"Liposomes as a novel ocular delivery system for brinzolamide: in vitro and in vivo studies","volume":"17","author":"Li","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"23","key":"10.1016\/j.jpet.2025.103738_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316864","article-title":"Liposomal encapsulation of citicoline for ocular drug delivery","volume":"24","author":"Bonechi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib82","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/neuonc\/noac019","article-title":"Repurposing the drug verteporfin as anti-neoplastic therapy for glioblastoma","volume":"24","author":"Read","year":"2022","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.jpet.2025.103738_bib83","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/03639045.2017.1349787","article-title":"New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment","volume":"43","author":"Li","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"issue":"20","key":"10.1016\/j.jpet.2025.103738_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015352","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103738_bib85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2017.07.035","article-title":"Novel nanosystems for the treatment of ocular inflammation: current paradigms and future research directions","volume":"268","author":"Lalu","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.jpet.2025.103738_bib86","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/IJN.S329831","article-title":"Ten years of knowledge of nano-carrier based drug delivery systems in ophthalmology: current evidence, challenges, and future prospective","volume":"16","author":"Zhang","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jpet.2025.103738_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108313","article-title":"Preparation and in vitro\/in vivo evaluations of novel ocular micelle formulations of hesperetin with glycyrrhizin as a nanocarrier","volume":"202","author":"Zhang","year":"2021","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib88","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/bjo.2004.060293","article-title":"Microglial stability and repopulation in the retina","volume":"89","author":"Albini","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103738_bib89","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2016.09.013","article-title":"Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model","volume":"513","author":"Wu","year":"2016","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib90","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.biomaterials.2011.10.010","article-title":"Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration","volume":"33","author":"Iezzi","year":"2012","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib91","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acsbiomaterials.7b00319","article-title":"Fast dissolving dendrimer nanofiber mats as alternative to eye drops for more efficient antiglaucoma drug delivery","volume":"3","author":"Lancina","year":"2017","journal-title":"ACS Biomater Sci Eng"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103738_bib92","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2013.11.043","article-title":"Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits","volume":"461","author":"Mishra","year":"2014","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib93","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nano.2011.08.018","article-title":"Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs","volume":"8","author":"Holden","year":"2012","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.jpet.2025.103738_bib94","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/molecules26113419","article-title":"Topical astodrimer sodium, a non-toxic polyanionic dendrimer, demonstrates antiviral activity in an experimental ocular adenovirus infection model","volume":"26","author":"Romanowski","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103738_bib95","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2021.05.035","article-title":"Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration","volume":"335","author":"Kambhampati","year":"2021","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11095-018-2556-5","article-title":"Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa\u00ae) for dry eye disease","volume":"36","author":"Mandal","year":"2019","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/jop.2012.0232","article-title":"Dendrimer nanoparticles for ocular drug delivery","volume":"29","author":"Kambhampati","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.jpet.2025.103738_bib98","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1021\/acs.molpharmaceut.6b00182","article-title":"Novel water-soluble mucoadhesive carbosilane dendrimers for ocular administration","volume":"13","author":"Bravo-Osuna","year":"2016","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib99","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/biom9080330","article-title":"Cytotoxicity of dendrimers","volume":"9","author":"Janaszewska","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/gels7010026","article-title":"Microemulsions as solubilizers and penetration enhancers for minoxidil release from gels","volume":"7","author":"\u0160paglov\u00e1","year":"2021","journal-title":"Gels"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib101","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mabi.201100419","article-title":"Nanomaterials for ocular drug delivery","volume":"12","author":"Liu","year":"2012","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.jpet.2025.103738_bib102","first-page":"380","article-title":"Nanotechnology meets atopic dermatitis: current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature","volume":"4","author":"Damiani","year":"2019","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jpet.2025.103738_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105229","article-title":"Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus","volume":"144","author":"Zhang","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib104","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13346-019-00697-0","article-title":"Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide","volume":"10","author":"Bhalerao","year":"2020","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.jpet.2025.103738_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118979","article-title":"Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment","volume":"576","author":"Juri\u0161i\u0107 Dukovski","year":"2020","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103738_bib106","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","article-title":"Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits","volume":"443","author":"Tayel","year":"2013","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib107","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C2SM06903B","article-title":"Nanoemulsions versus microemulsions: terminology, differences, and similarities","volume":"8","author":"McClements","year":"2012","journal-title":"Soft Matter"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib108","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3109\/10717544.2015.1116025","article-title":"Advance of the application of nano-controlled release system in ophthalmic drug delivery","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib109","first-page":"1635","article-title":"A stable hydrocortisone nanosuspension for improved dissolution: preparation, characterization and in vitro evaluation","volume":"30","author":"Ali","year":"2017","journal-title":"Pak J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103738_bib110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2013.07.002","article-title":"Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation","volume":"455","author":"Luschmann","year":"2013","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib111","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/jps.24101","article-title":"Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen","volume":"103","author":"Abrego","year":"2014","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib112","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijpharm.2017.03.082","article-title":"Improved release of triamcinolone acetonide from medicated soft contact lenses loaded with drug nanosuspensions","volume":"525","author":"Garc\u00eda-Mill\u00e1n","year":"2017","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib113","first-page":"592","article-title":"Improved ocular bioavailability of moxifloxacin HCl using PLGA nanoparticles: fabrication, characterization, in-vitro and in-vivo evaluation","volume":"20","author":"Khan","year":"2021","journal-title":"Iran J Pharm Res"},{"issue":"12","key":"10.1016\/j.jpet.2025.103738_bib114","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1021\/acs.molpharmaceut.1c00370","article-title":"Cyclosporine A nanosuspensions for ophthalmic delivery: a comparative study between cationic nanoparticles and drug-core mucus penetrating nanoparticles","volume":"18","author":"Yan","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jpet.2025.103738_bib115","article-title":"Chitosan grafted methoxy poly(ethylene glycol)-poly(\u03b5-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac","volume":"5","author":"Shi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103738_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114046","article-title":"Naturally derived mucoadhesive nanosuspension for treatment of multiple staged ocular infections","volume":"386","author":"Zheng","year":"2025","journal-title":"J Control Release"},{"issue":"21","key":"10.1016\/j.jpet.2025.103738_bib117","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3390\/polym13213746","article-title":"A review on electrospun nanofibers based advanced applications: from health care to energy devices","volume":"13","author":"Reddy","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jpet.2025.103738_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213124","article-title":"Recent advancements in polymeric nanofibers for ophthalmic drug delivery and ophthalmic tissue engineering","volume":"141","author":"Sakpal","year":"2022","journal-title":"Biomater Adv"},{"key":"10.1016\/j.jpet.2025.103738_bib119","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actbio.2017.10.015","article-title":"Electrospun formulations of bevacizumab for sustained release in the eye","volume":"64","author":"Angkawinitwong","year":"2017","journal-title":"Acta Biomater"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1208\/s12249-021-02051-5","article-title":"Polyvinyl alcohol\/chitosan single-layered and polyvinyl alcohol\/chitosan\/eudragit RL100 multi-layered electrospun nanofibers as an ocular matrix for the controlled release of ofloxacin: an in vitro and in vivo evaluation","volume":"22","author":"Mirzaeei","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib121","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s11095-017-2155-x","article-title":"Cyclosporine A loaded electrospun poly(D,L-lactic acid)\/poly(ethylene glycol) nanofibers: drug carriers utilizable in local immunosuppression","volume":"34","author":"Sirc","year":"2017","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib122","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/polym14030427","article-title":"The effect of polymers on drug release kinetics in nanoemulsion in situ gel formulation","volume":"14","author":"Vijaya Rani","year":"2022","journal-title":"Polymers (Basel)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib123","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.21509","article-title":"Gold nanoparticles in ophthalmology","volume":"39","author":"Masse","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jpet.2025.103738_bib124","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2019.01.004","article-title":"Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: in vitro and in vivo evaluation","volume":"86","author":"Maulvi","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jpet.2025.103738_bib125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tiv.2016.08.013","article-title":"Biocompatibility of gold nanoparticles in retinal pigment epithelial cell line","volume":"37","author":"Karako\u00e7ak","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.jpet.2025.103738_bib126","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jphotobiol.2018.08.014","article-title":"Biosynthesis, characterization and cytotoxicity of gold nanoparticles and their loading with N-acetylcarnosine for cataract treatment","volume":"187","author":"Wang","year":"2018","journal-title":"J Photochem Photobiol B"},{"issue":"16","key":"10.1016\/j.jpet.2025.103738_bib127","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/molecules24162929","article-title":"Synthesis of ultrastable gold nanoparticles as a new drug delivery system","volume":"24","author":"Masse","year":"2019","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jpet.2025.103738_bib128","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1039\/C9NR00376B","article-title":"Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease","volume":"11","author":"Li","year":"2019","journal-title":"Nanoscale"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105359","article-title":"Silver and gold nanoparticles exposure to in vitro cultured retina\u2013studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity","volume":"9","author":"S\u00f6derstjerna","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib130","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.nano.2017.03.016","article-title":"Intraocular application of gold nanodisks optically tuned for optical coherence tomography: inhibitory effect on retinal neovascularization without unbearable toxicity","volume":"13","author":"Song","year":"2017","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib131","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/j.msec.2013.06.037","article-title":"Photochemical and antimicrobial properties of silver nanoparticle-encapsulated chitosan functionalized with photoactive groups","volume":"33","author":"Mathew","year":"2013","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib132","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/pathogens9050350","article-title":"Silver nanoparticles as a novel potential preventive agent against Acanthamoeba keratitis","volume":"9","author":"Hendiger","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.jpet.2025.103738_bib133","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.biopha.2017.04.079","article-title":"In vitro antioxidant and anticataractogenic potential of silver nanoparticles biosynthesized using an ethanolic extract of Tabernaemontana divaricata leaves","volume":"91","author":"Anbukkarasi","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2025.103738_bib134","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.2147\/IJN.S109695","article-title":"Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis","volume":"11","author":"Yang","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib135","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3109\/17435390.2012.676099","article-title":"Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles","volume":"7","author":"Kim","year":"2013","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.jpet.2025.103738_bib136","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.2147\/IJN.S244785","article-title":"Silver nanoparticle-induced apoptosis in ARPE-19 cells is inhibited by Toxoplasma gondii pre-infection through suppression of NOX4-dependent ROS generation","volume":"15","author":"Quan","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib137","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/pharmaceutics10040167","article-title":"Porous inorganic carriers based on silica, calcium carbonate and calcium phosphate for controlled\/modulated drug delivery: fresh outlook and future perspectives","volume":"10","author":"Trofimov","year":"2018","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib138","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/0885328220977605","article-title":"Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus","volume":"35","author":"Paiva","year":"2021","journal-title":"J Biomater Appl"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib139","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.nano.2011.09.003","article-title":"Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor","volume":"8","author":"Jo","year":"2012","journal-title":"Nanomedicine"},{"issue":"34","key":"10.1016\/j.jpet.2025.103738_bib140","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1039\/C7TB01217A","article-title":"Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma","volume":"5","author":"Liao","year":"2017","journal-title":"J Mater Chem B"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib141","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1021\/acs.molpharmaceut.8b00215","article-title":"Amino-functionalized mesoporous silica particles for ocular delivery of brimonidine","volume":"15","author":"Kim","year":"2018","journal-title":"Mol Pharm"},{"issue":"33","key":"10.1016\/j.jpet.2025.103738_bib142","doi-asserted-by":"crossref","first-page":"21107","DOI":"10.1021\/acsami.6b00371","article-title":"Temperature-responsive smart nanocarriers for delivery of therapeutic agents: applications and recent advances","volume":"8","author":"Karimi","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202205754","article-title":"Functional carbon quantum dots for ocular imaging and therapeutic applications","volume":"19","author":"Kumar","year":"2023","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.jpet.2025.103738_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.11.9.1","article-title":"Carbon nanostructures for ocular tissue reinforcement","volume":"11","author":"Silvestre","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"10.1016\/j.jpet.2025.103738_bib145","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.3390\/ijms21082957","article-title":"Graphene oxide-based nanomaterials: an insight into retinal prosthesis","volume":"21","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103738_bib146","article-title":"Timolol-eluting graphene oxide laden silicone contact lens: control release profile with improved critical lens properties","volume":"69","author":"Maulvi","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib147","doi-asserted-by":"crossref","first-page":"446","DOI":"10.18502\/jovr.v15i4.7778","article-title":"Penetration of carbon nanotubes into the retinoblastoma tumor after intravitreal injection in LHBETA TAG transgenic mice reti-noblastoma model","volume":"15","author":"Demirci","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jpet.2025.103738_bib148","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biomaterials.2016.10.018","article-title":"Carbon nanotube electrodes for retinal implants: a study of structural and functional integration over time","volume":"112","author":"Eleftheriou","year":"2017","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.jpet.2025.103738_bib149","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.3390\/ma14216707","article-title":"Carbon nanotubes: current perspectives on diverse applications in targeted drug delivery and therapies","volume":"14","author":"Rahamathulla","year":"2021","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.jpet.2025.103738_bib150","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s11434-013-5800-8","article-title":"Cytotoxicity and genotoxicity of multi-walled carbon nanotubes with human ocular cells","volume":"58","author":"Yan","year":"2013","journal-title":"Chin Sci Bull"},{"key":"10.1016\/j.jpet.2025.103738_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.882803","article-title":"Comparison of seven cyclosporine A formulations for dry eye disease: a systematic review and network meta-analysis","volume":"13","author":"Gao","year":"2022","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.jpet.2025.103738_bib152","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/ICO.0000000000001989","article-title":"Effect of OTX-101, a novel nanomicellar formulation of cyclosporine A, on corneal staining in patients with keratoconjunctivitis sicca: a pooled analysis of phase 2b\/3 and phase 3 studies","volume":"38","author":"Malhotra","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jpet.2025.103738_bib153","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2147\/OPTH.S465143","article-title":"Tolerability of current treatments for dry eye disease: a review of approved and investigational therapies","volume":"18","author":"Gupta","year":"2024","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jpet.2025.103738_bib154","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jop.2018.0106","article-title":"Ocular distribution of cyclosporine following topical administration of OTX-101 in New Zealand white rabbits","volume":"35","author":"Weiss","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103738_bib155","first-page":"1","article-title":"Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications","volume":"11","author":"Kalomiraki","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib156","volume":"5","author":"Eroglu","year":"2017","journal-title":"J Mark Access Health Policy"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib157","article-title":"Nanoparticle-enhanced ocular drug delivery system: formulation, characterization, and therapeutic efficacy","volume":"13","author":"Suriyaprakash","year":"2024","journal-title":"Front Health Inform"},{"key":"10.1016\/j.jpet.2025.103738_bib158","doi-asserted-by":"crossref","first-page":"37","DOI":"10.12659\/MSMBR.883750","article-title":"The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy","volume":"19","author":"Xu","year":"2013","journal-title":"Med Sci Monit Basic Res"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib159","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/pharmaceutics15041094","article-title":"Overcoming treatment challenges in posterior segment diseases with biodegradable nano-based drug delivery systems","volume":"15","author":"Wu","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib160","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpet.2025.103738_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120807","article-title":"PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up","volume":"605","author":"Operti","year":"2021","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib162","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/blr.2011.9814","article-title":"Guidance for industry considering whether an FDA-regulated product involves the application of nanotechnology","volume":"30","year":"2011","journal-title":"Biotechnol Law Rep"},{"issue":"3","key":"10.1016\/j.jpet.2025.103738_bib163","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jps.23879","article-title":"Nanotherapeutics\u2013product development along the \u201cnanomaterial\u201d discussion","volume":"103","author":"Wacker","year":"2014","journal-title":"J Pharm Sci"},{"issue":"24","key":"10.1016\/j.jpet.2025.103738_bib164","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.3390\/jcm13247651","article-title":"Nanomedicine in ophthalmology: from bench to bedside","volume":"13","author":"Mahaling","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpet.2025.103738_bib165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2021.06.016","article-title":"Methodological needs in the quality and safety characterisation of nanotechnology-based health products: priorities for method development and standardisation","volume":"336","author":"Halamoda-Kenzaoui","year":"2021","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.jpet.2025.103738_bib166","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1633","article-title":"Nonclinical regulatory immunotoxicity testing of nanomedicinal products: proposed strategy and possible pitfalls","volume":"12","author":"Giannakou","year":"2020","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"30","key":"10.1016\/j.jpet.2025.103738_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301956","article-title":"Feeding next-generation nanomedicines to Europe: regulatory and quality challenges","volume":"12","author":"Musazzi","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib168","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.drudis.2017.01.016","article-title":"Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?","volume":"22","author":"Musazzi","year":"2017","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.jpet.2025.103738_bib169","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci Adv"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103738_bib170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2014.02.038","article-title":"A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases","volume":"465","author":"Apaolaza","year":"2014","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib171","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/pharmaceutics15061591","article-title":"Dendrimers in corneal drug delivery: recent developments and translational opportunities","volume":"15","author":"Dhull","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jpet.2025.103738_bib172","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s10792-021-01763-8","article-title":"New pharmacotherapy options for noninfectious posterior uveitis","volume":"41","author":"Pleyer","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103738_bib173","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/jpm3010040","article-title":"Personalized medicine in ophthalmology: from pharmacogenetic biomarkers to therapeutic and dosage optimization","volume":"3","author":"Ong","year":"2013","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.jpet.2025.103738_bib174","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4103\/IJO.IJO_2851_22","article-title":"Tear proteomics in dry eye disease","volume":"71","author":"Kannan","year":"2023","journal-title":"Indian J Ophthalmol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:03:50Z","timestamp":1777421030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":173,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022356525402511"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103738","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances and future challenges in nanosystems for ocular drug delivery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103738"}}